Clinical Trials Directory

Trials / Completed

CompletedNCT03474224

Hemodynamic Optimization During Major Urological Surgery

Correlation Between IN-TArget Time for Mean Arterial Pressure and Stroke Volume During Major Urological Surgery and Tissue Perfusion: the INTAT Observational Study

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

In this prospective observational study investigators aim to seek for any possible correlation between the venous to arterial carbon dioxide difference (pCO2 gap) at the end of surgery and the percentage of time spent above a predefined threshold of stroke volume (SV) andn mean arterial pressure (MAP).

Detailed description

During major urological surgery (i.e. cistectomy) investigators will use a minimally invasive hemodynamic monitoring system (Flotrac - Vigileo, Edwards ) to guide fluid therapy and vasopressors administration. More specifically stroke volume target will be defined as the maximum SV after a series of fluid boluses, with a 10% tolerance. MAP was considered adequate if above 65 mmHg. After the induction of anesthesia, then each hour during surgery until the end of surgical procedure investigators will assess the time of adherence to the hemodynamic protocol (in terms of both SV and MAP) and the correspondent pCO2 gap. Investigators expect to find an inverse proportionality between the two parameters explored.

Conditions

Interventions

TypeNameDescription
DEVICEEv1000 Clinical Platform from Edwards LifesciencesThe EV1000 Hemodynamic monitoring platform will be used to guide fluid administration following a volume-based parameter such the stroke volume.

Timeline

Start date
2018-10-05
Primary completion
2020-07-21
Completion
2020-07-28
First posted
2018-03-22
Last updated
2022-06-07

Locations

1 site across 1 country: Italy

Regulatory

Source: ClinicalTrials.gov record NCT03474224. Inclusion in this directory is not an endorsement.